Market Introduction
Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.
Market Overview and Dynamics
The Europe Neuromodulation market is projected to reach US$ 4,741.75 million by 2027 from US$ 2,296.33 million in 2019; it is estimated to grow with a CAGR of 9.8% from 2020 to 2027. The growth of the Europe neuromodulation market is attributed to the increasing incidence of neurological disorders, growing developments in neuromodulation technology. However, high cost of neuromodulation devices the growth of market in this region. leading to restraining the growth of the market.
Key Market Segments
Based on technology, the Europe neuromodulation market is segmented into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment held a larger share of the market. External (non-invasive) neuromodulation is expected to grow at a faster rate during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to while preparing the Europe neuromodulation market report are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.
Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim.
Reasons to buy the report
EUROPE NEUROMODULATION MARKET SEGMENTATION
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,296.33 Million |
| Market Size by 2027 | US$ 4,741.75 Million |
| CAGR (2020 - 2027) | 9.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Neuromodulation Market is valued at US$ 2,296.33 Million in 2019, it is projected to reach US$ 4,741.75 Million by 2027.
As per our report Europe Neuromodulation Market, the market size is valued at US$ 2,296.33 Million in 2019, projecting it to reach US$ 4,741.75 Million by 2027. This translates to a CAGR of approximately 9.8% during the forecast period.
The Europe Neuromodulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neuromodulation Market report:
The Europe Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Neuromodulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Neuromodulation Market
